← Back to Modular Medical Stock
Modular Medical (MODD) News
Pre-clinical study to explore use of MODD1 pump as a delivery system for FDA-approved, short acting peptides, as a personalized alternative for people who discontinue long-acting GLP-1 formulations SAN DIEGO, CA / ACCESSWIRE / July 15, 2024 / Modular Medical, Inc. (NASDAQ:MODD) ("Modular Medical" or the "Company"), an insulin delivery technology company seeking to launch the next generation of user-friendly and affordable insulin pump technology, today announced a proof-of-concept study with Gubra A/S ("Gubra") in a high-fat, diet-induced obese ("DIO") mouse model to explore the potential future use of the MODD1 pump platform to assist patients who struggle with tolerability, inconsistent efficacy, and cost of long acting GLP-1 therapies. "A recent study published by Blue Health Intelligence using data from a national dataset of private insurers found that about half of all patients prescribed a GLP-1 drug for weight loss discontinued after the first 12 weeks, with approximately 30% discontinuing in the first four weeks," commented Jeb Besser, Chief Executive Officer of Modular Medical.
Modular Medical (NASDAQ: MODD ) just reported results for the fourth quarter of 2024. Modular Medical reported earnings per share of -14 cents. This was above the analyst estimate for EPS of -17 cents. The company did not report any revenue for the quarter. InvestorPlace Earnings is a project that leverages data from TradeSmith to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at editor@investorplace.com. More From InvestorPlace The #1 AI Investment Might Be This Company You’ve Never Heard Of Musk’s “Project Omega” May Be Set to Mint New Millionaires. Here’s How to Get In. Legendary Investor Predicts: “Forget A.I. THIS Technology Is the Future” The post MODD Stock Earnings: Modular Medical Beats EPS for Q4 2024 appeared first on InvestorPlace .
https://www.investing.com/news/company-news/modular-medical-set-to-join-russell-microcap-index-93CH-3468234
SAN DIEGO, CA / ACCESSWIRE / June 3, 2024 / Modular Medical, Inc. (NASDAQ:MODD) ("Modular Medical"), a development-stage, insulin delivery technology company seeking to launch the next generation of user-friendly and affordable insulin pump technology, today announced that it is set to join the Russell Microcap Index at the conclusion of the 2024 Russell indexes annual reconstitution, effective when the U.S. market opens on July 1, 2024. Membership in the Russell Microcap Index, which remains in place for one year, means automatic inclusion in the appropriate growth and value style indexes.
SAN DIEGO, CA / ACCESSWIRE / May 21, 2024 / Modular Medical, Inc. (NASDAQ:MODD) ("Modular Medical" or the "Company"), a development-stage, insulin delivery technology company seeking to launch the …
MADISON, Wis., May 20, 2024 /PRNewswire/ -- Madison Liquidators, a leading online office furniture supplier, today announced the release of their newest video featuring the Boss Office Products' Modular L-Shaped desk with Storage. The video introduces viewers to this versatile and stylish desk solution through thoughtfully crafted videography and narration. "We are excited to introduce the Boss L Shaped Desk which is the most affordable and best-selling in its class. The video provides customers a real-world glimpse of the desk, without having to visit our store in person," states Madison Liquidators CEO, Nick Niesen. "This desk is a great option for those who are looking for a stylish and functional solution for their home office or workspace." Storage for the desk includes a 2-drawer lateral filing cabinet available in different sizes and finishes with customers' choice of drawers for the desk. In addition to its storage capabilities, the L-Shaped desk with storage also features grommets that allow for power and charging units to create a more organized workspace that can reasonably suit devices of all types. Madison Liquidators offers a wide variety of office desk options, all of which boast quality and comfort, but they are proud to showcase this latest addition to the lineup. The Modular L-Shaped desk with Storage is constructed from scratch-resistant laminate with availability in three separate finishes and a variety of sizes to suit any workspace. As previously stated, the desk comes standard with a two-drawer and a three-drawer pedestal, but there are various other storage options available, including an under-desk pencil drawer, a sliding keyboard tray, and even external storage options. Madison Liquidators offers a wide variety of new, used, and refurbished furniture to meet the needs of any business or home office. The company is committed to providing quality furniture at affordable prices, and a manufacturer's guarantee backs all its products. The Boss Office Products L Shaped Desk is available for purchase at Madisonliquidators.com.
SAN DIEGO, CA / ACCESSWIRE / March 26, 2024 / Modular Medical, Inc. (NASDAQ:MODD) ("Modular Medical" or the "Company"), a development-stage, insulin delivery technology company seeking to launch the next generation of user-friendly and affordable … Jetzt den vollständigen Artikel lesen
SAN DIEGO, CA / ACCESSWIRE / March 26, 2024 / Modular Medical, Inc. (NASDAQ:MODD) ("Modular Medical" or the "Company"), a development-stage, insulin delivery technology company seeking to launch the next generation of user-friendly and affordable insulin pump technology, today announced the addition of Steve Gemmell as Vice President of Engineering. Gemmell has over 20 years of experience in medical device product development and operations and previously held R&D leadership positions with Cytrellis Biosystems, Inc., Onduo, a joint venture between Sanofi SA and Verily Life Sciences, and Insulet Corporation.
Meet with Modular Medical CEO, Jeb BesserThere are more than 3 million individuals who use daily insulin to help with the care of Diabetes in the US. 100% of patient population require daily insuli…
Meet with Modular Medical CEO, Jeb Besser There are more than 3 million individuals who use daily insulin to help with the care of Diabetes in the US. 100% of patient population require daily insulin injection.